Hiroko Nogi
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
-
- Cancer Treatment and Pharmacology
- Cancer Diagnosis and Treatment
Papers in
- Oncology 20
- Cancer Cells and Metastasis 5
- Cancer Treatment and Pharmacology 4
- Cancer Diagnosis and Treatment 4
-
- Breast Cancer Treatment Studies 15
- Co-authors
- Hiroshi Takeyama (18 shared papers)Yasuo Toriumi (18 shared papers)Ken Uchida (16 shared papers)Naoki Agata (3 shared papers)Donald Küfe (3 shared papers)Tadashi Kobayashi (8 shared papers)Kazumi Kawase (8 shared papers)Masafumi Suzuki (5 shared papers)
- Journals
- Breast Cancer (11 papers)Cancer Research (4 papers)Annals of Surgical Oncology (2 papers)Journal of Clinical Oncology (2 papers)Cancer (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Hiroko Nogi
38 papers receiving 372 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 160
- Oncology 155
- Dermatology 41
- Pathology and Forensic Medicine 69
- Pulmonary and Respiratory Medicine 96
Countries citing papers authored by Hiroko Nogi
This map shows the geographic impact of Hiroko Nogi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Nogi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Nogi more than expected).
Fields of papers citing papers by Hiroko Nogi
This network shows the impact of papers produced by Hiroko Nogi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Nogi. The network helps show where Hiroko Nogi may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroko Nogi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 91 | |
| 2 | 2008 | 35 | |
| 3 | 2004 | 32 | |
| 4 | 2013 | 27 | |
| 5 | 2017 | 18 | |
| 6 | 2017 | 14 | |
| 7 | 2009 | 13 | |
| 8 | 2008 | 12 | |
| 9 | 2023 | 11 | |
| 10 | 2006 | 11 | |
| 11 | 2015 | 11 | |
| 12 | 2003 | 10 | |
| 13 | 2021 | 9 | |
| 14 | 2023 | 8 | |
| 15 | 2022 | 7 | |
| 16 | 2022 | 7 | |
| 17 | 2019 | 6 | |
| 18 | 2005 | 6 | |
| 19 | 2014 | 6 | |
| 20 | 2015 | 5 |
About Hiroko Nogi
Hiroko Nogi is a scholar working on Oncology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 41 papers that have together received 380 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (15 papers), Breast Implant and Reconstruction (9 papers), Breast Lesions and Carcinomas (6 papers), Cancer Cells and Metastasis (5 papers), Cancer Treatment and Pharmacology (4 papers), Cancer Diagnosis and Treatment (4 papers), Reconstructive Surgery and Microvascular Techniques (4 papers) and Cancer and Skin Lesions (4 papers). The work is most often cited by research in Cancer Research (160 citations), Oncology (155 citations), Dermatology (41 citations), Pathology and Forensic Medicine (69 citations) and Pulmonary and Respiratory Medicine (96 citations). Hiroko Nogi has collaborated with scholars based in Japan and United States. Frequent co-authors include Hiroshi Takeyama, Yasuo Toriumi, Ken Uchida, Naoki Agata, Donald Küfe, Tadashi Kobayashi, Kazumi Kawase, Masafumi Suzuki, Michael A. Milhollen and Surender Kharbanda. Their work appears in journals such as Breast Cancer, Cancer Research, Annals of Surgical Oncology, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.